Windtree Therapeutics, Inc. (NasdaqCM:WINT) is looking for acquisitions. Craig Fraser, Chief Executive Officer said, "Mid to longer term, we believe there could be opportunity to leverage our internal programs, partner deal revenue, a strengthened balance sheet and public company liquidity to selectively execute other potential acquisitions and/or strategic transactions to grow the business and its value".
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.295 USD | +2.33% | +2.33% | -74.54% |
15/05 | Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | Windtree Therapeutics Seeks Acquisitions | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.54% | 19.06L | |
+21.45% | 4.69TCr | |
+37.63% | 3.91TCr | |
-8.38% | 3.85TCr | |
+29.03% | 3.1TCr | |
-13.75% | 2.61TCr | |
+11.02% | 2.59TCr | |
+36.20% | 1.25TCr | |
-6.60% | 1.14TCr | |
-12.43% | 1.06TCr |
- Stock Market
- Equities
- WINT Stock
- News Windtree Therapeutics, Inc.
- Windtree Therapeutics Seeks Acquisitions